Intellectual Property Partners

Transforming your ideas into IP assets.

“Since 2017 IP2 is rated year by year among the top 300 IP strategy law firms world wide”

IAM300

Intellectual Property Partners

Transforming your ideas into IP assets.

“Since 2017 IP2 is rated year by year among the top 300 IP strategy law firms world wide”

IAM300

Our Services

Tech Areas

Dispute

Deal

Protect

Dr. Bernd Fabry

Bernd Fabry is founder and CEO of IP2. He is a qualified German and European Patent and Trademark Attorney. He has more than 25 years company experience as Head of IP departments. For a decade he was lecturer of IP Management at Otto-Beisheim School of Management in Vallendar and has authored numerous papers and books in the field of IP protection.

Dr. Bernd Fabry

Bernd Fabry is founder and CEO of IP2. He is a qualified German and European Patent and Trademark Attorney. He has more than 25 years company experience as Head of IP departments. For a decade he was lecturer of IP Management at Otto-Beisheim School of Management in Vallendar and has authored numerous papers and books in the field of IP protection.

Stefanie Daniels

Stefanie Daniels is Managing Director at IP2 and also a qualified German and European Patent and Trademark Attorney. She  is specialized on molecular biology, biochemistry, organic chemistry, genetics, toxicology and pharmacology. 

Stefanie Daniels

Stefanie Daniels is Managing Director at IP2 and also a qualified German and European Patent and Trademark Attorney. She  is specialized on molecular biology, biochemistry, organic chemistry, genetics, toxicology and pharmacology. 

Downloads

Employee Inventors Rights

Overview of German employee invention law at the „Lunes de Patentes“ event, in particular with regard to employer obligations, inventors compensation and lump-sum remuneration models.

Trademarks as strategic management tools

Learn more about the economic value of trademarks, the registration requirements, the enforcement of marks and go through a number of case studies on the subject of likelihood of confusion. This presentation was given at the WHU Business School Düsseldorf.

Our breaking offer

We file your trademark (DE, EU) at a fix rate of EUR 199,- within 24 hours (taxes and office fees not included)

We build the future

 As of January 1, 2019, we announce the association with our US colleagues Dilworth & Barrese, LLP.

Latest News

What the IP community drives

Intel becomes victim of patent trolls

Intel becomes victim of patent trolls

Dubious business model Patent trolls are well-funded companies that have no research and development of their own and whose business model is to buy up patents at low prices and then try to enforce them against alleged (or actual) infringers. Last year, for example,...

DeepMind’s AlphaFold: The beginning of a new area in medicine

DeepMind’s AlphaFold: The beginning of a new area in medicine

Proteins are biological nano-machines that power every living thing on our planet. While the variety of known proteins is extraordinary, all proteins consist of 20 simple building blocks called amino acids. The precise sequence of amino acids is encoded in our DNA and...

Molnupiravir: The next cure for Cov-2?

Molnupiravir: The next cure for Cov-2?

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug originally developed by Emory University for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral effect...